Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The TEC family kinase group is the second largest family of non-receptor tyrosine kinases, playing crucial roles in intracellular signaling, especially within hematopoietic and immune cells. These kinases are signal transducers activated by a variety of cell surface receptors, including antigen receptors, integrins, growth factors, cytokines, and G protein-coupled receptors. BTK inhibitors represent an important class of drugs targeting this family for autoimmune diseases and certain cancers. Many small-molecule inhibitors show cross-reactivity among TEC-family members due to structural similarities within their active sites.
Inhibition of TEC family kinase activity
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TEC Family Kinase (TEC Kinases).